Skip to content

David M Compton

2 papers in the library · 37 citations · publishing 2006-2011

Papers

5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence.

Physiology & behavior May 3, 2011 David M Compton, Kerri L Dietrich, Melissa C Selinger et al. 21 citations

The recreational hallucinogen 5-MeO-DIPT (Foxy or Methoxy Foxy) impairs cognitive flexibility in rats when administered during adolescence. Rats given repeated injections of 5 or 20 mg/kg of the drug during one of two adolescent periods were later tested as adults on spatial memory and nonspatial tasks. Drug-treated rats performed as well as controls on spatial navigation to a fixed goal, but were markedly inferior when the goal moved to a new location and on a response learning task, indicating reduced ability to adapt to changing demands. The drug also reduced serotonin activity in the forebrain, similar to MDMA, suggesting it compromises serotonergic systems.

An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.

Psychological reports June 1, 2006 David M Compton, Melissa C Selinger, Erin K Testa et al. 16 citations

Rats given the hallucinogenic drug 5-MeO-DIPT (Foxy) during adolescence performed comparably to controls on most spatial navigation tests but were markedly worse on a response-learning task, indicating reduced flexibility in adapting to changing demands. This pattern resembles effects of MDMA and suggests 5-MeO-DIPT may compromise serotonin systems in the forebrain.